Atom Investors LP Grows Stock Holdings in McKesson Corporation $MCK

Atom Investors LP lifted its position in shares of McKesson Corporation (NYSE:MCK) by 282.1% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 10,505 shares of the company’s stock after buying an additional 7,756 shares during the quarter. McKesson makes up 0.7% of Atom Investors LP’s holdings, making the stock its 23rd largest holding. Atom Investors LP’s holdings in McKesson were worth $8,617,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. University of Texas Texas AM Investment Management Co. purchased a new position in shares of McKesson during the 4th quarter valued at $25,000. Swiss RE Ltd. purchased a new position in shares of McKesson during the 4th quarter valued at $26,000. GGM Financials LLC purchased a new position in shares of McKesson during the 3rd quarter valued at $25,000. State of Wyoming purchased a new position in shares of McKesson during the 2nd quarter valued at $29,000. Finally, Board of the Pension Protection Fund purchased a new position in shares of McKesson during the 4th quarter valued at $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

McKesson Price Performance

NYSE:MCK opened at $786.55 on Wednesday. The firm has a market capitalization of $92.09 billion, a P/E ratio of 20.45, a PEG ratio of 1.28 and a beta of 0.31. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The company’s fifty day moving average price is $794.00 and its 200-day moving average price is $844.72.

McKesson (NYSE:MCK) last released its quarterly earnings data on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. The firm had revenue of $96.30 billion for the quarter, compared to analyst estimates of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The business’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $10.12 earnings per share. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities analysts anticipate that McKesson Corporation will post 44.28 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be given a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s dividend payout ratio (DPR) is currently 8.53%.

Analyst Ratings Changes

A number of research firms recently weighed in on MCK. Raymond James Financial set a $970.00 target price on shares of McKesson in a research note on Thursday, March 5th. Leerink Partners reiterated an “outperform” rating and issued a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. UBS Group lifted their price target on shares of McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a report on Friday, May 8th. Weiss Ratings downgraded shares of McKesson from a “buy (b+)” rating to a “buy (b)” rating in a report on Monday, May 18th. Finally, Wall Street Zen upgraded shares of McKesson from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Fourteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, McKesson currently has an average rating of “Moderate Buy” and a consensus target price of $960.53.

Insider Activity

In related news, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the firm’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $764.00, for a total transaction of $101,612.00. Following the sale, the chief accounting officer owned 632 shares in the company, valued at approximately $482,848. This trade represents a 17.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Thomas L. Rodgers sold 699 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $735.27, for a total transaction of $513,953.73. Following the sale, the executive vice president owned 2,268 shares in the company, valued at approximately $1,667,592.36. This represents a 23.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 11,822 shares of company stock worth $8,986,212 in the last ninety days. Corporate insiders own 0.08% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.